Evidence map›Paper›PMID 42222171›Full record

ArticleFrontiers in pharmacology2026

Structure-guided hydrophobic modulation at the 3-position of

Javier Palacios, Chia Ling Yu González, Diego Aravena, Javier Romero-Parra, Maximiliano Martínez-Cifuentes, Claudio Parra

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Javier PalaciosLaboratorio de Bioquímica Aplicada, Química y Farmacía, Facultad de Ciencias de la Salud, Universidad Arturo Prat, Iquique, Chile.
Chia Ling Yu GonzálezLaboratorio de Bioquímica Aplicada, Química y Farmacía, Facultad de Ciencias de la Salud, Universidad Arturo Prat, Iquique, Chile.
Diego AravenaLaboratorio de Bioquímica Aplicada, Química y Farmacía, Facultad de Ciencias de la Salud, Universidad Arturo Prat, Iquique, Chile.
Javier Romero-ParraDepartamento de Química Orgánica y Fisicoquímica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile.
Maximiliano Martínez-CifuentesDepartamento de Química Orgánica, Facultad de Ciencias Químicas, Universidad de Concepción, Concepción, Chile.
Claudio ParraDepartamento de Química Orgánica, Facultad de Ciencias Químicas, Universidad de Concepción, Concepción, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypertension is a major global health challenge driven by sustained alterations in vascular tone and dysregulation of the renin-angiotensin system (RAS). Although natural products provide valuable scaffolds for vascular drug discovery, systematic structure-function studies linking defined hydrophobic modifications to vascular mechanisms remain limited. This study aimed to evaluate how hydrophobic substitution at the three-position of chalcones derived from Methods: A focused series of chalcones bearing either an allyl or a prenyl substituent at the three-position was synthesized and evaluated. Vasorelaxant effects were assessed in isolated aortic rings from spontaneously hypertensive rats under receptor-mediated (phenylephrine), depolarization-induced (KCl), and angiotensin I-induced contractile conditions. Molecular docking studies were performed to explore interactions with the angiotensin-converting enzyme (ACE) catalytic site, and Results: All chalcones induced concentration-dependent relaxation in precontracted aortic rings; however, their pharmacological profiles depended on the nature of the 3-substituent. The prenylated derivative CHAL 13 showed the most consistent activity across complementary vascular models, retaining inhibitory effects under depolarizing conditions and significantly attenuating angiotensin I-induced contraction. In contrast, the allylated derivative CHAL A showed a more limited mechanistic profile: although retaining activity in phenylephrine-precontracted rings, it exhibited weaker inhibition under depolarizing conditions and markedly lower ACE inhibitory potency Conclusion: Hydrophobic substitution at the three-position is a relevant determinant of the vascular behavior of S. nutans-derived chalcones. Prenylation favors a broader vasoactive profile associated with interference in Ca

Indexed as

angiotensin-converting enzymechalconehypertensionSenecio nutans Sch.-Bip.vascular smooth muscle

Identifiers

PMID42222171
PMCPMC13219365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.